Swiss contract drug manufacturer Lonza's plants in the United States and Switzerland are due to make ingredients for 400 million doses of Moderna's COVID-19 vaccine annually, Lonza said on Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback